| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 11.00B | 12.12B | 18.95B | 18.06B | 22.38B |
| Gross Profit | 5.78B | 7.77B | 9.05B | 8.84B | 11.31B |
| EBITDA | 1.02B | -5.29B | 3.75B | 1.30B | 10.31B |
| Net Income | 50.00M | -3.22B | 945.00M | -1.71B | 6.02B |
Balance Sheet | |||||
| Total Assets | 198.51B | 190.04B | 204.88B | 221.75B | 253.70B |
| Cash, Cash Equivalents and Short-Term Investments | 19.87B | 9.72B | 11.59B | 14.65B | 23.56B |
| Total Debt | 17.91B | 16.85B | 19.43B | 19.96B | 36.74B |
| Total Liabilities | 46.09B | 47.57B | 56.67B | 66.04B | 87.32B |
| Stockholders Equity | 146.71B | 136.83B | 142.99B | 151.59B | 162.02B |
Cash Flow | |||||
| Free Cash Flow | 3.89B | 3.60B | 1.80B | 5.83B | 2.08B |
| Operating Cash Flow | 4.02B | 3.83B | 2.38B | 6.18B | 2.55B |
| Investing Cash Flow | 6.42B | -2.59B | -3.55B | 4.31B | 11.31B |
| Financing Cash Flow | -652.00M | -3.72B | -1.75B | -17.55B | -7.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$401.63B | 6.70 | 3.55% | 3.89% | 4.66% | 26.27% | |
74 Outperform | HK$179.01B | 12.36 | 2.75% | 4.33% | 27.01% | -20.16% | |
73 Outperform | HK$248.87B | 7.63 | 8.88% | 5.18% | 1.05% | -0.55% | |
67 Neutral | HK$118.01B | 15.34 | 2.20% | 5.62% | 30.32% | -1.37% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
58 Neutral | HK$73.47B | 1,328.77 | 0.03% | 1.76% | -9.23% | ― | |
58 Neutral | HK$171.40B | 8.19 | 3.54% | 4.54% | -9.39% | -19.08% |